vimarsana.com

Rolling Submission Process News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Market cap of CureVac N V [CVAC] reaches 20 03B – now what?

Review process started with submission of first CVnCoV data package. A sum of 1885608 shares traded at recent session while its average daily volume was at 983.85K shares. CureVac N.V. shares reached a high of $116.75 and dropped to a low of $106.26 until finishing in the latest session at $109.13. The one-year CVAC stock forecast points to a potential downside of -29.59. The average equity rating for CVAC stock is currently 2.60, trading closer to a bullish pattern in the stock market. Guru’s Opinion on CureVac N.V. [CVAC]: Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVAC shares is $84.21 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVAC stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell,

Investegate |CureVac Announcements | CureVac: CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic

Investegate |CureVac Announcements | CureVac: CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.